Date: Thursday 9 May 2019
Venue: Royal Society of Chemistry, London, W1J 0BA
Organised by: Joint Pharmaceutical Analysis Group
Overview: The quality of Aseptic products is the most critical challenge in the pharmaceutical industry. It covers those medicinal products that cannot be terminally sterilised, the majority of new injectable IMPs and all gene therapy and ATMPs. In addition, 2019 is a vitally important year as the revised Annex 1 becomes globally implemented and provides a host of challenges for the industry trying to implement it. JPAG has been able to bring together a unique and almost unparalleled group of speakers in a programme that tries to cover the hottest topics in this field.
Event link: www.jpag.org/113
Sponsors: Royal Pharmaceutical Society and Royal Society of Chemistry